期刊文献+

急性冠状动脉综合征患者雷帕霉素洗脱支架晚期贴壁不良及其对临床预后的影响 被引量:3

Association between late incomplete stent apposition after sirolimus eluting stent implantation and clinical outcomes in patients with acute coronary syndrome
原文传递
导出
摘要 目的观察急性冠状动脉综合征(ACS)患者雷帕霉素洗脱支架晚期贴壁不良发生率及其对临床预后的影响。方法观察2005年2月至2007年3月因ACS(ACS组,54例)和稳定性心绞痛(对照组,83例)行雷帕霉素洗脱支架治疗并于1年后行血管内超声检查患者,检测支架晚期贴壁不良发生率,并观察血管内超声检查后1年内主要不良心血管事件及支架内血栓发生率。结果所有137例患者219处病变中,16例患者25处病变检测到晚期支架贴壁不良。25处晚期支架贴壁不良中ACS组和对照组分别为20处(22.2%)和5处(3.9%)(P〈0.001)。两组患者参照血管外弹力膜面积、参照血管和支架段血管管腔面积和新生内膜面积均相似,但ACS组患者支架段血管外弹力膜面积[(15.34±5.44)mm^2比(13.83±4.51)mm^2,P=0.026]、支架段血管外弹力膜面积与参照血管外弹力膜面积比值(1.13±O.22比1.02±0.18,P〈0.001)、斑块和中膜面积[(8.43±3.93)mm^2比(7.01±2.93)mm^2,P=0.002]较对照组明显增大。Logistic多元回归分析显示,ACS(OR=6.477,P〈0.001)和支架长度≥23mm(OR=3.680,P=0.025)为晚期支架贴壁不良的独立危险因素。血管内超声检查后临床随访1年,两组主要不良心血管事件发生率差异无统计学意义。结论雷帕霉素洗脱支架置入后,ACS患者较稳定性心绞痛患者更多发生晚期支架贴壁不良,然而随访1年的主要不良心血管事件发生率差异无统计学意义。 Objective The impact of late incomplete stent apposition (ISA) post sirolimus eluting stent (SES) implantation in patients with acute coronary syndrome (ACS) on long-term clinical outcomes remains controversial. The aim of the present study was to evaluate the association between late ISA and clinical outcomes in patients with ACS compared with that with stable angina (SA). Methods From February 2005 to March 2007, 54 ACS patients and 83 SA patients were enrolled in this study, late ISA was determined by means of three-dimensional volumetric intravascular ultrasound (IVUS) analyses one year after SES implantation and clinical outcomes one year post IVUS were obtained in these patients. Results In 219 treated lesions of the 137 patients, late ISA was documented in 25 lesions in 16 patients (20 ISA in 12 ACS patients vs. 5 ISA in 4 SA patients, P 〈 0. 001 ). Though lumen area in reference and stented segment, neointimal hyperplasia (NIH) area and percentage of NIH in stented segment, and external elastic membrane (EEM) area in reference segment were similar between two groups, EEM area in stented segment [ ( 15. 34 ±5.44) mm^2 vs. ( 13.83 ±4. 51 )mm^2, P = 0. 026 ], stented/reference segment EEM area ratio (1.13~0.22vs. 1.02+0.18, P〈 0.001), plaque and media area [(8.43±3.93) mm^2vs. (7.01 ±2. 93) mm^2, P = 0. 002] was significantly lager in ACS group than that in SA group. Multivariable logistic analysis showed that ACS ( OR 6.477 with 95% CI from 2. 297 to 18. 263, P 〈 0. 001 ) and stent length ≥ 23 mm (OR 3.680 with 95% CI from 1. 181 to 11.469, P =0.025) were main independent factors of occurrence of late ISA. Incidence of main adverse cardiac events (MACE) one year post IVUS was similar between the two groups. Conclusion Compared with patients with SA, ACS patients had larger stented segment EEM area,plaque and media area as well as increased incidence of ISA. However,the incidence of MACE was similar in ACS and SA patients one year after IVUS.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2009年第1期30-34,共5页 Chinese Journal of Cardiology
关键词 冠状动脉疾病 支架 超声检查 介入性 Coronary disease Stents Ultrasonography, interventional
  • 相关文献

参考文献21

  • 1Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol, 2005,45:1397-1405.
  • 2Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med, 2002,346 : 1773-1780.
  • 3Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003,349:1315-1323.
  • 4Tanabe K, Serruys PW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS Ⅱ trial. Circulation, 2005,111:900-905.
  • 5Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation, 2004,109:851-856.
  • 6Abizaid A, Albertal M, Costa MA, et al. First human experience with the 17-beta-estradiol-eluting stent: the Estrogen And Stents To Eliminate Restenosis (EASTER) trial. J Am Coll Cardiol, 2004,43 : 1118-1121.
  • 7Cutlip DE, Windecker S, Mehran R,et al. Clinical end points in coronary stent trials : a case for standardized definitions. Circulation, 2007,115:2344-2351.
  • 8Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA, 2005,293:2126-2130.
  • 9Cutlip DE, Bairn DS, Ho KK, et al. Stent thrombosis in the modem era: a pooled analysis of muhicenter coronary stent clinical trials. Circulation, 2001,103 : 1967-1971.
  • 10Daemen J, Tanimoto S, Garcta-Garcia HM, et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stems versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T- SEARCH Rezistries). Am J Cardiol. 2007.99:1027-1032.

同被引文献32

  • 1Lagerqvist B,James SK,Stenestrand U,et al.Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden[J].N Engl J Med,2007,356(10):1009-1019.
  • 2Cook S,Wenaweser P,Togni M,et al.Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation[J].Circulation,2007,115(18):2426-2434.
  • 3Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials:a case for standardized definitions[J].Circulation,2007,115(17):2344-2351.
  • 4Hoffmann R, Morice MC, Moses JW, et al. hnpact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart,2008,94:322-328.
  • 5Sanchez-Recalde A, Moreno R, Barreales L, et al. Risk of late- acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials. J Invasive Cardio1,2008 ,20 :417-422.
  • 6Jimenez-Quevedo P, Sabate M, Angiolillo D J, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the diabetes and sirolimus-eluting stent (DIABETES) trial. J Am Coil Cardiol, 2006, 47:2172-2179.
  • 7Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coil Cardiol, 2005,46: 1002-1005.
  • 8Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation, 2006, 113 : 414- 419.
  • 9Miyazawa A, Tsujino I, Ako J, et al. Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents. J Invasive Cardiol,2007, 19:515-518.
  • 10Qian J, Zhang F, Wu H, et al. Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation. Int J Cardiovasc Imaging,2008,24 : 133-139.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部